{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:48:30Z","timestamp":1792032510199,"version":"4.4.0"},"reference-count":199,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.beha.2005.07.010","type":"journal-article","created":{"date-parts":[[2006,6,15]],"date-time":"2006-06-15T13:25:13Z","timestamp":1150377913000},"page":"595-615","source":"Crossref","is-referenced-by-count":58,"title":["Pathogenesis, clinical features, and treatment advances in mastocytosis"],"prefix":"10.1016","volume":"19","author":[{"given":"A.","family":"Pardanani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6061","key":"10.1016\/j.beha.2005.07.010_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/320415a0","article-title":"A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family","volume":"320","author":"Besmer","year":"1986","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.beha.2005.07.010_bib2","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/j.1460-2075.1987.tb02655.x","article-title":"Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand","volume":"6","author":"Yarden","year":"1987","journal-title":"The Embo Journal"},{"key":"10.1016\/j.beha.2005.07.010_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.bi.57.070188.002303","article-title":"Growth factor receptor tyrosine kinases","volume":"57","author":"Yarden","year":"1988","journal-title":"Annual Review of Biochemistry"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/j.1460-2075.1988.tb02907.x","article-title":"Primary structure of c-kit: relationship with the CSF-1\/PDGF receptor kinase family\u2014oncogenic activation of v-kit involves deletion of extracellular domain and C terminus","volume":"7","author":"Qiu","year":"1988","journal-title":"The Embo Journal"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00291740","article-title":"Localization of the human c-kit protooncogene on the q11-q12 region of chromosome 4","volume":"78","author":"d'Auriol","year":"1988","journal-title":"Human Genetics"},{"issue":"6185","key":"10.1016\/j.beha.2005.07.010_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/335088a0","article-title":"The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus","volume":"335","author":"Chabot","year":"1988","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(88)90020-7","article-title":"The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene","volume":"55","author":"Geissler","year":"1988","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/genetics\/97.2.337","article-title":"Analysis of pleiotropism at the dominant white-spotting (W) locus of the house mouse: a description of ten new W alleles","volume":"97","author":"Geissler","year":"1981","journal-title":"Genetics"},{"issue":"6","key":"10.1016\/j.beha.2005.07.010_bib9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1101\/gad.3.6.816","article-title":"Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice\u2014evidence for an impaired c-kit kinase in mutant mice","volume":"3","author":"Nocka","year":"1989","journal-title":"Genes and Development"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1101\/gad.4.3.390","article-title":"W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor","volume":"4","author":"Reith","year":"1990","journal-title":"Genes and Development"},{"issue":"16","key":"10.1016\/j.beha.2005.07.010_bib11","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1073\/pnas.89.16.7816","article-title":"Spontaneous malignant transformation of melanocytes explanted from Wf\/Wf mice with a Kit kinase-domain mutation","volume":"89","author":"Larue","year":"1992","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"12A","key":"10.1016\/j.beha.2005.07.010_bib12","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1101\/gad.5.12a.2265","article-title":"Ectopic expression of a c-kitW42 minigene in transgenic mice: recapitulation of W phenotypes and evidence for c-kit function in melanoblast progenitors","volume":"5","author":"Ray","year":"1991","journal-title":"Genes and Development"},{"issue":"11","key":"10.1016\/j.beha.2005.07.010_bib13","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1073\/pnas.88.11.4811","article-title":"Mouse platelet-derived growth factor receptor alpha gene is deleted in W19H and patch mutations on chromosome 5","volume":"88","author":"Smith","year":"1991","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"4939","key":"10.1016\/j.beha.2005.07.010_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1126\/science.1688471","article-title":"The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase","volume":"247","author":"Tan","year":"1990","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.beha.2005.07.010_bib15","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/j.1460-2075.1991.tb07784.x","article-title":"Signal transduction by normal isoforms and W mutant variants of the kit receptor tyrosine kinase","volume":"10","author":"Reith","year":"1991","journal-title":"The Embo Journal"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.89.2.678","article-title":"Interkinase domain of kit contains the binding site for phosphatidylinositol 3\u2032 kinase","volume":"89","author":"Lev","year":"1992","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"2 supplement","key":"10.1016\/j.beha.2005.07.010_bib17","doi-asserted-by":"crossref","first-page":"176S","DOI":"10.1038\/jid.1993.10","article-title":"White mutants in mice shedding light on humans","volume":"100","author":"Halaban","year":"1993","journal-title":"Journal of Investigative Dermatology"},{"issue":"21","key":"10.1016\/j.beha.2005.07.010_bib18","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/sj.onc.1205317","article-title":"Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease","volume":"21","author":"Scheijen","year":"2002","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.beha.2005.07.010_bib19","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V80.9.2237.2237","article-title":"Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor\/kit-ligand in long-term culture","volume":"80","author":"Valent","year":"1992","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4049\/jimmunol.148.3.772","article-title":"Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells","volume":"148","author":"Kirshenbaum","year":"1992","journal-title":"The Journal of Immunology"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2567.1996.d01-733.x","article-title":"Stem cell factor potentiates histamine secretion by multiple mechanisms, but does not affect tumour necrosis factor-alpha release from rat mast cells","volume":"89","author":"Lin","year":"1996","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.beha.2005.07.010_bib22","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.4049\/jimmunol.159.11.5560","article-title":"Functional properties of human intestinal mast cells cultured in a new culture system: enhancement of IgE receptor-dependent mediator release and response to stem cell factor","volume":"159","author":"Bischoff","year":"1997","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0092-8674(90)90300-4","article-title":"Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver\u2014conditioned medium","volume":"63","author":"Zsebo","year":"1990","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0092-8674(90)90298-S","article-title":"Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles","volume":"63","author":"Copeland","year":"1990","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(90)90303-V","article-title":"The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus","volume":"63","author":"Huang","year":"1990","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0092-8674(90)90302-U","article-title":"Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor","volume":"63","author":"Zsebo","year":"1990","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0092-8674(90)90297-R","article-title":"Identification of a ligand for the c-kit proto-oncogene","volume":"63","author":"Williams","year":"1990","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.beha.2005.07.010_bib28","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1073\/pnas.88.11.4671","article-title":"Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains","volume":"88","author":"Brannan","year":"1991","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0092-8674(91)90326-T","article-title":"Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant","volume":"64","author":"Flanagan","year":"1991","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1091\/mbc.3.3.349","article-title":"Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2","volume":"3","author":"Huang","year":"1992","journal-title":"Molecular Biology of the Cell"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1634\/stemcells.2004-0117","article-title":"Normal and oncogenic forms of the receptor tyrosine kinase kit","volume":"23","author":"Lennartsson","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.beha.2005.07.010_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/aja.1000400203","article-title":"A study of the hereditary anemia of the mouse","volume":"40","author":"De Aberle","year":"1927","journal-title":"American Journal of Anatomy"},{"key":"10.1016\/j.beha.2005.07.010_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1073\/pnas.23.10.535","article-title":"The occurence of a dominant spotting mutation in the house mouse","volume":"23","author":"Little","year":"1937","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.beha.2005.07.010_bib34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/genetics\/24.6.777","article-title":"Inherited macrocytic anemias in the house mouse","volume":"24","author":"Gruneberg","year":"1939","journal-title":"Genetics"},{"key":"10.1016\/j.beha.2005.07.010_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02982903","article-title":"Inherited macrocytic anemias of the house mouse. II. Dominance relationships","volume":"43","author":"Gruneberg","year":"1942","journal-title":"Journal of Genetics"},{"issue":"6","key":"10.1016\/j.beha.2005.07.010_bib36","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/genetics\/34.6.708","article-title":"Analysis of pleiotropism at the W-locus in the mouse; relationship between the effects of W and Wv substitution on hair pigmentation and on erythrocytes","volume":"34","author":"Russell","year":"1949","journal-title":"Genetics"},{"key":"10.1016\/j.beha.2005.07.010_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jez.1401260207","article-title":"Analysis of the pleotropism at the W locus in the mouse. The effects of W and Wv substitutions upon post natal development of germ cells","volume":"126","author":"Coulombre","year":"1954","journal-title":"Journal of Experimental Zoology"},{"key":"10.1016\/j.beha.2005.07.010_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1073\/pnas.27.2.114","article-title":"Some effects of the gene Wv (dominant white spotting) in the mouse","volume":"27","author":"Fekete","year":"1941","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib39","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/genetics\/53.5.949","article-title":"Analysis of pleiotropic effects of W and f genic substitutions in the mouse","volume":"53","author":"Russell","year":"1966","journal-title":"Genetics"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib40","first-page":"191","article-title":"Genetically mast-cell-deficient W\/Wv and Sl\/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo","volume":"127","author":"Galli","year":"1987","journal-title":"American Journal of Pathology"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib41","first-page":"38","article-title":"Migration of stromal cells supporting mast-cell differentiation into open wound produced in the skin of mice","volume":"9","author":"Matsuda","year":"1981","journal-title":"Experimental Hematology"},{"issue":"5619","key":"10.1016\/j.beha.2005.07.010_bib42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/268442a0","article-title":"Development of mast cells from grafted bone marrow cells in irradiated mice","volume":"268","author":"Kitamura","year":"1977","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood.V52.2.447.447","article-title":"Decrease of mast cells in W\/Wv mice and their increase by bone marrow transplantation","volume":"52","author":"Kitamura","year":"1978","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib44","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/blood.V53.3.492.492","article-title":"Decreased production of mast cells in S1\/S1d anemic mice","volume":"53","author":"Kitamura","year":"1979","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib45","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1084\/jem.150.3.482","article-title":"Distribution of mast-cell precursors in hematopoeitic and lymphopoietic tissues of mice","volume":"150","author":"Kitamura","year":"1979","journal-title":"The Journal of Experimental Medicine"},{"issue":"5727","key":"10.1016\/j.beha.2005.07.010_bib46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/281154a0","article-title":"Clonal nature of mast-cell clusters formed in W\/Wv mice after bone marrow transplantation","volume":"281","author":"Kitamura","year":"1979","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib47","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0012-1606(79)90042-3","article-title":"Presence of mast cell precursors in fetal liver of mice","volume":"70","author":"Kitamura","year":"1979","journal-title":"Developmental Biology"},{"issue":"6","key":"10.1016\/j.beha.2005.07.010_bib48","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood.V53.6.1085.1085","article-title":"Presence of mast cell precursors in peripheral blood of mice demonstrated by parabiosis","volume":"53","author":"Kitamura","year":"1979","journal-title":"Blood"},{"issue":"5811","key":"10.1016\/j.beha.2005.07.010_bib49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/291159a0","article-title":"Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes","volume":"291","author":"Kitamura","year":"1981","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1182\/blood.V53.1.142.142","article-title":"Local development of mast cells from bone marrow-derived precursors in the skin of mice","volume":"53","author":"Hatanaka","year":"1979","journal-title":"Blood"},{"issue":"3 Pt 2","key":"10.1016\/j.beha.2005.07.010_bib51","first-page":"681","article-title":"[Significance of cell-to-cell interaction for migration and proliferation: an application of W and Sl mutant mice for cancer research]","volume":"11","author":"Kitamura","year":"1984","journal-title":"Gan To Kagaku Ryoho"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jcp.1041080315","article-title":"Precursor of mast cells fixed in the skin of mice","volume":"108","author":"Matsuda","year":"1981","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.beha.2005.07.010_bib53","first-page":"557","article-title":"Long-continued function of normal blood-forming tissue transplanted into genetically anemic hosts","volume":"23","author":"Russell","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood.V26.4.399.399","article-title":"The cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype Sl\u2013Sld","volume":"26","author":"McCulloch","year":"1965","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib55","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Butterfield","year":"1988","journal-title":"Leukemia Research"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib56","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto- oncogene c-kit in a human mast cell leukemia cell line causing ligand- independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"Journal of Clinical Investigation"},{"issue":"9","key":"10.1016\/j.beha.2005.07.010_bib57","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood.V83.9.2619.2619","article-title":"Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation","volume":"83","author":"Tsujimura","year":"1994","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib58","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000236870","article-title":"Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3","volume":"106","author":"Tsujimura","year":"1995","journal-title":"International Archives of Allergy and Immunology"},{"issue":"23","key":"10.1016\/j.beha.2005.07.010_bib59","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"8","key":"10.1016\/j.beha.2005.07.010_bib60","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0301-472X(03)00112-7","article-title":"Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit","volume":"31","author":"Akin","year":"2003","journal-title":"Experimental Hematology"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib61","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1046\/j.1365-2141.1997.d01-2042.x","article-title":"A new c-kit mutation in a case of aggressive mast cell disease","volume":"96","author":"Pignon","year":"1997","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/1096-8652(200012)65:4<307::AID-AJH10>3.0.CO;2-F","article-title":"Mast cell disease associated with acute myeloid leukemia: detection of a new c-kit mutation Asp816His","volume":"65","author":"Pullarkat","year":"2000","journal-title":"American Journal of Hematology"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib63","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proceedings of the National Academy of Sciences USA"},{"issue":"8","key":"10.1016\/j.beha.2005.07.010_bib64","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2005.07.010_bib65","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1136\/jmg.2003.015156","article-title":"A germline mutation in KIT in familial diffuse cutaneous mastocytosis","volume":"41","author":"Tang","year":"2004","journal-title":"Journal of Medical Genetics"},{"issue":"6","key":"10.1016\/j.beha.2005.07.010_bib66","first-page":"1227","article-title":"Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior","volume":"111","author":"Buttner","year":"1998","journal-title":"Journal of Medical Genetics"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib67","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D","article-title":"Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa","volume":"92","author":"Beghini","year":"2001","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10428190400010775","article-title":"Mastocytosis: pathology, genetics, and current options for therapy","volume":"46","author":"Valent","year":"2005","journal-title":"Leukemia and Lymphoma"},{"issue":"8","key":"10.1016\/j.beha.2005.07.010_bib69","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood.V87.8.3117.bloodjournal8783117","article-title":"A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells","volume":"87","author":"Piao","year":"1996","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib70","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V85.3.790.bloodjournal853790","article-title":"Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines","volume":"85","author":"Kitayama","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib71","first-page":"189","article-title":"Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line","volume":"148","author":"Hashimoto","year":"1996","journal-title":"American Journal of Pathology"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib72","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.V88.3.995.995","article-title":"Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase","volume":"88","author":"Kitayama","year":"1996","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2005.07.010_bib73","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0145-2126(02)00272-2","article-title":"Constitutively active mutant D816VKit induces megakayocyte and mast cell differentiation of early haemopoietic cells from murine foetal liver","volume":"27","author":"Ferrao","year":"2003","journal-title":"Leukemia Research"},{"key":"10.1016\/j.beha.2005.07.010_bib74","doi-asserted-by":"crossref","first-page":"141a","DOI":"10.1182\/blood.V104.11.485.485","article-title":"c-kit D816V provides a strong signal for myelomastocytic differentiation and cluster formation in murine Ba\/F3 cells","volume":"104","author":"Mayerhofer","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib75","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2002-01-0203","article-title":"Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene","volume":"100","author":"Yavuz","year":"2002","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2005.07.010_bib76","first-page":"1525","article-title":"Altered apoptosis and cell cycling of mast cells in bone marrow lesions of patients with systemic mastocytosis","volume":"89","author":"Baldus","year":"2004","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib77","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/blood.V98.4.1195","article-title":"The Kit-activating mutation D816V enhances stem cell factor\u2014dependent chemotaxis","volume":"98","author":"Taylor","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib78","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4049\/jimmunol.149.2.599","article-title":"The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils","volume":"149","author":"Columbo","year":"1992","journal-title":"The Journal of Immunology"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s000110050045","article-title":"The effect of recombinant stem cell factor on human skin and lung mast cells and basophil leukocytes","volume":"46","author":"Frenz","year":"1997","journal-title":"Inflammation Research"},{"key":"10.1016\/j.beha.2005.07.010_bib80","doi-asserted-by":"crossref","first-page":"887","DOI":"10.7326\/0003-4819-59-6-887","article-title":"Systemic mast cell disease","volume":"59","author":"Mutter","year":"1963","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1016\/j.beha.2005.07.010_bib81","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0002-9343(91)90214-I","article-title":"Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis","volume":"91","author":"Lawrence","year":"1991","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1016\/j.beha.2005.07.010_bib82","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-198811000-00001","article-title":"Systemic mast cell disease. Analysis of 58 cases and literature review","volume":"67","author":"Travis","year":"1988","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.beha.2005.07.010_bib83","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.4065\/77.11.1169","article-title":"Systemic mast cell disease without associated hematologic disorder: a combined retrospective and prospective study","volume":"77","author":"Pardanani","year":"2002","journal-title":"Mayo Clinic Proceedings"},{"issue":"10","key":"10.1016\/j.beha.2005.07.010_bib84","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0145-2126(03)00065-1","article-title":"Eosinophils are derived from the neoplastic clone in patients with systemic mastocytosis and eosinophilia","volume":"27","author":"Pardanani","year":"2003","journal-title":"Leukemia Research"},{"issue":"10","key":"10.1016\/j.beha.2005.07.010_bib85","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1182\/blood-2004-03-0787","article-title":"FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia","volume":"104","author":"Pardanani","year":"2004","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.beha.2005.07.010_bib86","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"5350","key":"10.1016\/j.beha.2005.07.010_bib87","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"issue":"5607","key":"10.1016\/j.beha.2005.07.010_bib88","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib89","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1182\/blood.V98.3.880","article-title":"Association of the Q576R polymorphism in the interleukin-4 receptor alpha chain with indolent mastocytosis limited to the skin","volume":"98","author":"Daley","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2005.07.010_bib90","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0145-2126(01)00044-3","article-title":"Clinical and histopathological aspects of cutaneous mastocytosis","volume":"25","author":"Wolff","year":"2001","journal-title":"Leukemia Research"},{"issue":"7","key":"10.1016\/j.beha.2005.07.010_bib91","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leukemia Research"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archderm.97.2.137","article-title":"Genetic aspects of urticaria pigmentosa","volume":"97","author":"Shaw","year":"1968","journal-title":"Archives of Dermatological"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib93","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archderm.122.1.80","article-title":"Familial urticaria pigmentosa","volume":"122","author":"Fowler","year":"1986","journal-title":"Archives of Dermatological"},{"issue":"11","key":"10.1016\/j.beha.2005.07.010_bib94","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archderm.117.11.713","article-title":"Familial urticaria pigmentosa with giant mast cell granules. A clinical, light, and electron microscopic study","volume":"117","author":"James","year":"1981","journal-title":"Archives of Dermatological"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib95","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0889-8588(05)70295-1","article-title":"Mastocytosis and the skin","volume":"14","author":"Soter","year":"2000","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib96","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000048187","article-title":"Cutaneous mastocytosis\u2014clinical heterogeneity","volume":"127","author":"Hartmann","year":"2002","journal-title":"International Archives of Allergy and Immunology"},{"issue":"3 Pt 1","key":"10.1016\/j.beha.2005.07.010_bib97","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0091-6749(88)90015-2","article-title":"A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders","volume":"82","author":"Garriga","year":"1988","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib98","first-page":"32S","article-title":"The skin in mastocytosis","volume":"96","author":"Soter","year":"1991","journal-title":"Journal of Medical Genetics"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib99","first-page":"5S","article-title":"Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and women's hospital","volume":"96","author":"Horan","year":"1991","journal-title":"Journal of Medical Genetics"},{"issue":"2\u20134","key":"10.1016\/j.beha.2005.07.010_bib100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000024069","article-title":"Comparison of genetic and immunohistochemical findings in childhood and adult onset urticaria pigmentosa","volume":"118","author":"Buttner","year":"1999","journal-title":"International Archives of Allergy and Immunology"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib101","first-page":"15S","article-title":"Pediatric mastocytosis","volume":"96","author":"Kettelhut","year":"1991","journal-title":"Journal of Medical Genetics"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib102","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1525-1470.1994.tb00560.x","article-title":"Urticaria pigmentosa: a review of 67 pediatric cases","volume":"11","author":"Azana","year":"1994","journal-title":"Pediatric Dermatology"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib103","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1468-3083.2002.00370.x","article-title":"Comparison of mastocytosis with onset in children and adults","volume":"16","author":"Middelkamp Hup","year":"2002","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1016\/j.beha.2005.07.010_bib104","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archderm.1963.01590140008002","article-title":"The natural course of urticaria pigmentosa. Analysis and follow-up of 112 cases","volume":"87","author":"Caplan","year":"1963","journal-title":"Archives of Dermatological"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib105","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archderm.122.4.422","article-title":"The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid","volume":"122","author":"Ridell","year":"1986","journal-title":"Archives of Dermatological"},{"issue":"1 Pt 1","key":"10.1016\/j.beha.2005.07.010_bib106","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0190-9622(88)70007-9","article-title":"Bone marrow findings in adult patients with urticaria pigmentosa","volume":"18","author":"Czarnetzki","year":"1988","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib107","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/mp.53.4.188","article-title":"Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia","volume":"53","author":"Sotlar","year":"2000","journal-title":"Molecular Pathology"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib108","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","article-title":"One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes","volume":"162","author":"Sotlar","year":"2003","journal-title":"American Journal of Pathology"},{"issue":"8","key":"10.1016\/j.beha.2005.07.010_bib109","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0046-8177(85)80252-5","article-title":"Bone marrow findings in systemic mastocytosis","volume":"16","author":"Horny","year":"1985","journal-title":"Human Pathology"},{"issue":"7","key":"10.1016\/j.beha.2005.07.010_bib110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","article-title":"Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis","volume":"25","author":"Sperr","year":"2001","journal-title":"Leukemia Research"},{"issue":"7","key":"10.1016\/j.beha.2005.07.010_bib111","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","article-title":"Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings","volume":"25","author":"Horny","year":"2001","journal-title":"Leukemia Research"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib112","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1309\/2EWQKN00PG02JKY0","article-title":"Bone marrow biopsies for the diagnosis of systemic mastocytosis: is one biopsy sufficient?","volume":"121","author":"Butterfield","year":"2004","journal-title":"American Journal of Clinical Pathology"},{"issue":"9","key":"10.1016\/j.beha.2005.07.010_bib113","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","article-title":"Diagnostic value of immunostaining for tryptase in patients with mastocytosis","volume":"22","author":"Horny","year":"1998","journal-title":"American Journal of Surgical Pathology"},{"issue":"10","key":"10.1016\/j.beha.2005.07.010_bib114","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.pas.0000138181.89743.7b","article-title":"CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens","volume":"28","author":"Sotlar","year":"2004","journal-title":"American Journal of Surgical Pathology"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2559.1979.tb03017.x","article-title":"Mast cells and mast cell neoplasia: a review","volume":"3","author":"Lennert","year":"1979","journal-title":"Histopathology"},{"key":"10.1016\/j.beha.2005.07.010_bib116","series-title":"Mastocytosis and the Mast Cell","author":"Sagher","year":"1967"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib117","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/1097-0142(19820301)49:5<927::AID-CNCR2820490517>3.0.CO;2-B","article-title":"Systemic mast cell disease: a clinical and hematopathologic study of 26 cases","volume":"49","author":"Webb","year":"1982","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib118","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M","article-title":"Significance of systemic mast cell disease with associated hematologic disorders","volume":"62","author":"Travis","year":"1988","journal-title":"Cancer"},{"issue":"5\u20136","key":"10.1016\/j.beha.2005.07.010_bib119","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/10428190009058500","article-title":"Clinical and biologic diversity of leukemias occurring in patients with mastocytosis","volume":"37","author":"Sperr","year":"2000","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2141.1990.tb07870.x","article-title":"Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders","volume":"76","author":"Horny","year":"1990","journal-title":"British Journal of Haematology"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib121","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00000478-198307000-00005","article-title":"Systemic mastocytosis. Extracutaneous manifestations","volume":"7","author":"Brunning","year":"1983","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1016\/j.beha.2005.07.010_bib122","series-title":"Mastocytosis and the Mast Cell","author":"Sagher","year":"1967"},{"issue":"6","key":"10.1016\/j.beha.2005.07.010_bib123","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.2003.014860","article-title":"Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge","volume":"57","author":"Horny","year":"2004","journal-title":"Journal of Clinical Pathology"},{"issue":"11","key":"10.1016\/j.beha.2005.07.010_bib124","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0145-2126(02)00041-3","article-title":"Detection of c-kit point mutation Asp-816\u2192Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia","volume":"26","author":"Sotlar","year":"2002","journal-title":"Leukemia Research"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib125","first-page":"365","article-title":"Solid and hematologic malignancies in 60 patients with systemic mast cell disease","volume":"113","author":"Travis","year":"1989","journal-title":"Archives of Pathology & Laboratory Medicine"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib126","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0889-8588(03)00089-3","article-title":"Mast cell proliferative disorders: current view on variants recognized by the World Health Organization","volume":"17","author":"Valent","year":"2003","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"10.1016\/j.beha.2005.07.010_bib127","series-title":"World Health Organization (WHO) Classification of Tumors. Pathology and Genetics. Tumors of Hematopoietic and Lymphoid Tissues","first-page":"291","article-title":"Mastocytosis (mast cell disease)","author":"Valent","year":"2001"},{"issue":"10","key":"10.1016\/j.beha.2005.07.010_bib128","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood.V12.10.869.869","article-title":"Mast cell leukemia? Malignant mastocytosis with leukemia-like manifestations","volume":"12","author":"Efrati","year":"1957","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib129","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1182\/blood.V13.1.70.70","article-title":"Tissue mast cell leukemia","volume":"13","author":"Friedman","year":"1958","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/1097-0142(196601)19:1<134::AID-CNCR2820190115>3.0.CO;2-A","article-title":"Cytology of viable blood cells of tissue mast cell leukemia","volume":"19","author":"Schrek","year":"1966","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib131","first-page":"319","article-title":"[Acute mast-cell leukemia. Cytochemical and ultrastructural study, about a particular case (author's transl)]","volume":"15","author":"Daniel","year":"1975","journal-title":"Nouvelle Revue Francaise dapos; Hematologie"},{"key":"10.1016\/j.beha.2005.07.010_bib132","first-page":"142","article-title":"Mast cell leukemia and acute basophilic leukemia. Cytochemical studies","volume":"45","author":"Liso","year":"1978","journal-title":"Bibliotheca Haematologica"},{"issue":"9","key":"10.1016\/j.beha.2005.07.010_bib133","first-page":"1137","article-title":"A case of mastocytoma with leukemic manifestation of its immature form in the terminal stage (author's transl)","volume":"20","author":"Kimura","year":"1979","journal-title":"Rinsho Ketsueki"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib134","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2141.1980.tb03805.x","article-title":"Cytobiological and clinical aspects of tissue mast cell leukaemia","volume":"45","author":"Coser","year":"1980","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.1986.tb04133.x","article-title":"Mast cell leukaemia: evidence for bone marrow origin of the pathological clone","volume":"64","author":"Dalton","year":"1986","journal-title":"British Journal of Haematology"},{"issue":"12","key":"10.1016\/j.beha.2005.07.010_bib136","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0025-6196(12)62636-6","article-title":"Mast cell leukemia: report of a case and review of the literature","volume":"61","author":"Travis","year":"1986","journal-title":"Mayo Clinic Proceedings"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib137","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archinte.159.4.401","article-title":"Mastocytosis: diverse presentations and outcomes","volume":"159","author":"Pauls","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib138","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1572-0241.1998.106_c.x","article-title":"Systemic mastocytosis: a rare cause of noncirrhotic portal hypertension simulating autoimmune cholangitis\u2014report of four cases","volume":"93","author":"Kyriakou","year":"1998","journal-title":"American Journal of Gastroenterology"},{"issue":"5\u20136","key":"10.1016\/j.beha.2005.07.010_bib139","first-page":"222","article-title":"Aleukemic mast cell leukemia (formerly: \u2018malignant mastocytosis\u2019): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis","volume":"114","author":"Horny","year":"2002","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0320(19970415)30:2<98::AID-CYTO4>3.0.CO;2-9","article-title":"Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia","volume":"30","author":"Escribano","year":"1997","journal-title":"Cytometry"},{"issue":"11","key":"10.1016\/j.beha.2005.07.010_bib141","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1080\/10428190412331272695","article-title":"Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V","volume":"45","author":"Noack","year":"2004","journal-title":"Leukemia and Lymphoma"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib142","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.1986.tb04133.x","article-title":"Mast cell leukaemia: evidence for bone marrow origin of the pathological clone","volume":"64","author":"Dalton","year":"1986","journal-title":"British Journal of Haematology"},{"issue":"7","key":"10.1016\/j.beha.2005.07.010_bib143","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V98.7.2200","article-title":"Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia","volume":"98","author":"Sperr","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib144","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V95.2.726","article-title":"C-kit mutations in core binding factor leukemias","volume":"95","author":"Beghini","year":"2000","journal-title":"Blood"},{"issue":"3\u20134","key":"10.1016\/j.beha.2005.07.010_bib145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/10428199909167387","article-title":"Diagnosis of acute basophilic leukemia","volume":"32","author":"Duchayne","year":"1999","journal-title":"Leukemia and Lymphoma"},{"issue":"7","key":"10.1016\/j.beha.2005.07.010_bib146","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0145-2126(01)00040-6","article-title":"Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis","volume":"25","author":"Valent","year":"2001","journal-title":"Leukemia Research"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib147","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1365-2141.2002.03944.x","article-title":"Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients","volume":"119","author":"Casassus","year":"2002","journal-title":"British Journal of Haematology"},{"issue":"9383","key":"10.1016\/j.beha.2005.07.010_bib148","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(03)14115-3","article-title":"Imatinib therapy for systemic mast cell disease","volume":"362","author":"Pardanani","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib149","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0145-2126(03)00185-1","article-title":"Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine","volume":"28","author":"Pardanani","year":"2004","journal-title":"Leukemia Research"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0952-8180(90)90063-9","article-title":"Urticaria pigmentosa: an anesthetic challenge","volume":"2","author":"Greenblatt","year":"1990","journal-title":"Journal of Clinical Anesthesia"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib151","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/bja\/65.2.254","article-title":"Anaesthetic management of systemic mastocytosis","volume":"65","author":"Lerno","year":"1990","journal-title":"British Journal of Anaesthesia"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib152","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-198305000-00002","article-title":"Hazards in operative management of patients with systemic mastocytosis","volume":"197","author":"Scott","year":"1983","journal-title":"Annals of Surgery"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib153","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000542-197304000-00018","article-title":"Anesthetic considerations in mastocytosis","volume":"38","author":"Rosenbaum","year":"1973","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib154","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0091-6749(90)90067-E","article-title":"Cromolyn sodium in the management of systemic mastocytosis","volume":"85","author":"Horan","year":"1990","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib155","first-page":"9","article-title":"Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial","volume":"78","author":"Frieri","year":"1985","journal-title":"American Journal of Medical Genetics"},{"issue":"24","key":"10.1016\/j.beha.2005.07.010_bib156","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1056\/NEJM198012113032405","article-title":"Increased production of prostaglandin D2 in patients with systemic mastocytosis","volume":"303","author":"Roberts","year":"1980","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib157","first-page":"1","article-title":"Systemic mastocytosis: management of an unusual case with histamine (H1 and H2) antagonists and cyclooxygenase inhibition","volume":"10","author":"Crawhall","year":"1987","journal-title":"Clinical and Investigative Medicine"},{"issue":"10","key":"10.1016\/j.beha.2005.07.010_bib158","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0025-6196(12)61825-4","article-title":"Increased plasma calcitonin levels in systemic mast cell disease","volume":"69","author":"Yocum","year":"1994","journal-title":"Mayo Clinic Proceedings"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib159","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4065\/70.5.481","article-title":"Aspirin idiosyncrasy in systemic mast cell disease: a new look at mediator release during aspirin desensitization","volume":"70","author":"Butterfield","year":"1995","journal-title":"Mayo Clinic Proceedings"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0091-6749(83)90098-2","article-title":"Intervention with epinephrine in hypotension associated with mastocytosis","volume":"71","author":"Turk","year":"1983","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9","key":"10.1016\/j.beha.2005.07.010_bib161","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199202273260907","article-title":"Response to interferon alfa-2b in a patient with systemic mastocytosis","volume":"326","author":"Kluin-Nelemans","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib162","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2133.1998.02131.x","article-title":"Response of severe systemic mastocytosis to interferon alpha","volume":"138","author":"Butterfield","year":"1998","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib163","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2133.1995.tb02499.x","article-title":"Treatment of urticaria pigmentosa using interferon alpha","volume":"133","author":"Kolde","year":"1995","journal-title":"British Journal of Dermatology"},{"issue":"9","key":"10.1016\/j.beha.2005.07.010_bib164","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/rheumatology\/35.9.898","article-title":"Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B","volume":"35","author":"Lehmann","year":"1996","journal-title":"British Journal of Rheumatology"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00663015","article-title":"Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b","volume":"72","author":"Weide","year":"1996","journal-title":"Annals of Hematology"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib166","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.leukres.2004.05.003","article-title":"Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long-term follow-up of a case","volume":"29","author":"Butterfield","year":"2005","journal-title":"Leukemia Research"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib167","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0145-2126(03)00259-5","article-title":"Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature","volume":"28","author":"Hauswirth","year":"2004","journal-title":"Leukemia Research"},{"issue":"7","key":"10.1016\/j.beha.2005.07.010_bib168","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","article-title":"Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria","volume":"27","author":"Valent","year":"2003","journal-title":"Leukemia Research"},{"issue":"6","key":"10.1016\/j.beha.2005.07.010_bib169","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1365-2133.1996.tb07977.x","article-title":"Long-term effect of interferon alpha treatment in mastocytosis. [comment]","volume":"134","author":"Lippert","year":"1996","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000204898","article-title":"Anaphylactic-like syndrome in systemic mastocytosis treated with alpha- 2-interferon","volume":"85","author":"Pardini","year":"1991","journal-title":"Acta Haematologica"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib171","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM200101253440415","article-title":"Treatment of systemic mast-cell disease with cladribine","volume":"344","author":"Tefferi","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1016\/j.beha.2005.07.010_bib172","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0145-2126(02)00073-5","article-title":"Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis. Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma","volume":"26","author":"Escribano","year":"2002","journal-title":"Leukemia Research"},{"issue":"7","key":"10.1016\/j.beha.2005.07.010_bib173","first-page":"658","article-title":"Smoldering systemic mastocytosis. Successful therapy with cladribine","volume":"55","author":"Schleyer","year":"2004","journal-title":"Hautarzt"},{"issue":"13","key":"10.1016\/j.beha.2005.07.010_bib174","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","article-title":"Cladribine therapy for systemic mastocytosis","volume":"102","author":"Kluin-Nelemans","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.010_bib175","doi-asserted-by":"crossref","first-page":"190a","DOI":"10.1182\/blood.V104.11.661.661","article-title":"Efficacy and safety of cladribine in adult systemic mastocytosis","volume":"104","author":"Lortholary","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.beha.2005.07.010_bib176","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","article-title":"CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy","volume":"102","author":"Pardanani","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2005.07.010_bib177","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib178","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2003-08-2798","article-title":"Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome","volume":"103","author":"Klion","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib179","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.20088","article-title":"Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis","volume":"77","author":"Bain","year":"2004","journal-title":"American Journal of Hematology"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib180","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.leu.2403329","article-title":"Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis","volume":"18","author":"Elliott","year":"2004","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib181","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1532\/IJH97.04046","article-title":"Imatinib therapy in clonal eosinophilic disorders, including systemic mastocytosis","volume":"79","author":"Tefferi","year":"2004","journal-title":"International Journal of Hematology"},{"issue":"1","key":"10.1016\/j.beha.2005.07.010_bib182","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00062752-200401000-00009","article-title":"Clinical, genetic, and therapeutic insights into systemic mast cell disease","volume":"11","author":"Tefferi","year":"2004","journal-title":"Current Opinion in Hematology"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib183","first-page":"197","article-title":"Systemic mastocytosis: current concepts and treatment advances","volume":"3","author":"Tefferi","year":"2004","journal-title":"Current Hematology Reports"},{"issue":"9","key":"10.1016\/j.beha.2005.07.010_bib184","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2002-10-3103","article-title":"Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders","volume":"101","author":"Pardanani","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.beha.2005.07.010_bib185","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1182\/blood-2003-07-2393","article-title":"Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes","volume":"102","author":"Pitini","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2005.07.010_bib186","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.leukres.2003.09.001","article-title":"Inefficacy of imatinib-mesylate in sporadic, aggressive systemic mastocytosis","volume":"28","author":"Musto","year":"2004","journal-title":"Leukemia Research"},{"issue":"30","key":"10.1016\/j.beha.2005.07.010_bib187","doi-asserted-by":"crossref","first-page":"31655","DOI":"10.1074\/jbc.M403319200","article-title":"Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase","volume":"279","author":"Mol","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.beha.2005.07.010_bib188","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2004-12-4771","article-title":"In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation loop mutants of Kit","author":"Corbin","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.010_bib189","doi-asserted-by":"crossref","first-page":"228a","DOI":"10.1182\/blood.V104.11.797.797","article-title":"BMS-354825 is a Src\/Abl inhibitor with high nanomolar activity against the kit D816V mutation, which drives systemic mastocytosis and is imatinib-resistant","volume":"104","author":"Shah","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.07.010_bib190","doi-asserted-by":"crossref","first-page":"666a","DOI":"10.1182\/blood.V104.11.2424.2424","article-title":"BMS-354825 potently inhibits the kinase activity of KIT activation loop mutations associated with systemic mastocytosis and induces apoptosis of mastocytosis cell lines","volume":"104","author":"Schittenhelm","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2005.07.010_bib191","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1182\/blood-2004-06-2189","article-title":"Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970","volume":"104","author":"Corbin","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2005.07.010_bib192","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1182\/blood-2001-12-0350","article-title":"Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors","volume":"100","author":"Liao","year":"2002","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.beha.2005.07.010_bib193","first-page":"5729","article-title":"Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors","volume":"9","author":"Pryer","year":"2003","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"10.1016\/j.beha.2005.07.010_bib194","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2004-08-3247","article-title":"A novel NF-{kappa}B inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors","volume":"105","author":"Tanaka","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib195","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2003-07-2477","article-title":"17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells","volume":"103","author":"Fumo","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib196","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(03)00108-9","article-title":"PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease","volume":"3","author":"Cools","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2005.07.010_bib197","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2004-12-4617","article-title":"Activation mutations of human c-KIT resistant to imatinib are sensitive to the tyrosine kinase inhibitor PKC412","author":"Growney","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2005.07.010_bib198","first-page":"1431","article-title":"Trichostatin A induces apoptosis of p815 mastocytoma cells in histone acetylation- and mitochondria-dependent fashion","volume":"25","author":"Yee","year":"2004","journal-title":"International Journal of Oncology"},{"issue":"3","key":"10.1016\/j.beha.2005.07.010_bib199","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8588(05)70301-4","article-title":"Treatment of systemic mast cell disorders","volume":"14","author":"Worobec","year":"2000","journal-title":"Hematology\/Oncology Clinics of North America"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T18:58:45Z","timestamp":1683485925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692605000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":199,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1521692605000976"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2005.07.010","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}